Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

NCT06899529 is registered in ClinicalTrials.gov with Christian Ophthalmic Surgery Expedition Network as lead sponsor.

NCT NCT06899529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06899529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Lead sponsor
Christian Ophthalmic Surgery Expedition Network
Phase
Not applicable
Overall status
Recruiting
Start date
March 20, 2025
Completion date
May 20, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy - high risk